751 related articles for article (PubMed ID: 31800002)
21. Racial disparities in patients with head and neck squamous cell carcinoma.
Gourin CG; Podolsky RH
Laryngoscope; 2006 Jul; 116(7):1093-106. PubMed ID: 16826042
[TBL] [Abstract][Full Text] [Related]
22. Race does not impact pancreatic cancer treatment and survival in an equal access federal health care system.
Lee S; Reha JL; Tzeng CW; Massarweh NN; Chang GJ; Hetz SP; Fleming JB; Lee JE; Katz MH
Ann Surg Oncol; 2013 Dec; 20(13):4073-9. PubMed ID: 24002535
[TBL] [Abstract][Full Text] [Related]
23. Racial and Ethnic Disparity in Preoperative Chemosensitivity and Survival in Patients With Early-Stage Breast Cancer.
Roy AM; Patel A; Catalfamo K; Attwood K; Khoury T; Yao S; Gandhi S
JAMA Netw Open; 2023 Nov; 6(11):e2344517. PubMed ID: 37991763
[TBL] [Abstract][Full Text] [Related]
24. Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine Cancer.
Kucera CW; Tian C; Tarney CM; Presti C; Jokajtys S; Winkler SS; Casablanca Y; Bateman NW; Mhawech-Fauceglia P; Wenzel L; Hamilton CA; Chan JK; Jones NL; Rocconi RP; O'Connor TD; Farley JH; Shriver CD; Conrads TP; Phippen NT; Maxwell GL; Darcy KM
JAMA Netw Open; 2023 Apr; 6(4):e238437. PubMed ID: 37067801
[TBL] [Abstract][Full Text] [Related]
25. Oncologic and surgical outcomes for gastric cancer patients undergoing gastrectomy differ by race in the United States.
Tee MC; Pirozzi N; Brahmbhatt RD; Raman S; Franko J
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1941-1947. PubMed ID: 32466860
[TBL] [Abstract][Full Text] [Related]
26. Racial disparities in treatment and survival of male breast cancer.
Crew KD; Neugut AI; Wang X; Jacobson JS; Grann VR; Raptis G; Hershman DL
J Clin Oncol; 2007 Mar; 25(9):1089-98. PubMed ID: 17369572
[TBL] [Abstract][Full Text] [Related]
27. Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types.
Zhang C; Zhang C; Wang Q; Li Z; Lin J; Wang H
JAMA Netw Open; 2020 Apr; 3(4):e202950. PubMed ID: 32267515
[TBL] [Abstract][Full Text] [Related]
28. Determinants of black/white differences in colon cancer survival.
Mayberry RM; Coates RJ; Hill HA; Click LA; Chen VW; Austin DF; Redmond CK; Fenoglio-Preiser CM; Hunter CP; Haynes MA
J Natl Cancer Inst; 1995 Nov; 87(22):1686-93. PubMed ID: 7473817
[TBL] [Abstract][Full Text] [Related]
29. Association of Race and Ethnicity With Live Donor Kidney Transplantation in the United States From 1995 to 2014.
Purnell TS; Luo X; Cooper LA; Massie AB; Kucirka LM; Henderson ML; Gordon EJ; Crews DC; Boulware LE; Segev DL
JAMA; 2018 Jan; 319(1):49-61. PubMed ID: 29297077
[TBL] [Abstract][Full Text] [Related]
30. It's more than just cancer biology: Health disparities in patients with pancreatic neuroendocrine tumors.
Underwood PW; Riner AN; Neal D; Cameron ME; Yakovenko A; Reddy S; Rose JB; Hughes SJ; Trevino JG
J Surg Oncol; 2021 Dec; 124(8):1390-1401. PubMed ID: 34499741
[TBL] [Abstract][Full Text] [Related]
31. Changes in Racial Disparities in Mortality After Cancer Surgery in the US, 2007-2016.
Lam MB; Raphael K; Mehtsun WT; Phelan J; Orav EJ; Jha AK; Figueroa JF
JAMA Netw Open; 2020 Dec; 3(12):e2027415. PubMed ID: 33270126
[TBL] [Abstract][Full Text] [Related]
32. Black race independently predicts worse survival in uterine carcinosarcoma.
Erickson BK; Doo DW; Zhang B; Huh WK; Leath CA
Gynecol Oncol; 2014 May; 133(2):238-41. PubMed ID: 24613675
[TBL] [Abstract][Full Text] [Related]
33. Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.
Nee R; Martinez-Osorio J; Yuan CM; Little DJ; Watson MA; Agodoa L; Abbott KC
Am J Kidney Dis; 2015 Oct; 66(4):630-7. PubMed ID: 26002293
[TBL] [Abstract][Full Text] [Related]
34. Risk of pancreatic adenocarcinoma: disparity between African Americans and other race/ethnic groups.
Chang KJ; Parasher G; Christie C; Largent J; Anton-Culver H
Cancer; 2005 Jan; 103(2):349-57. PubMed ID: 15593353
[TBL] [Abstract][Full Text] [Related]
35. Racial disparity in consultation, treatment, and the impact on survival in metastatic colorectal cancer.
Simpson DR; Martínez ME; Gupta S; Hattangadi-Gluth J; Mell LK; Heestand G; Fanta P; Ramamoorthy S; Le QT; Murphy JD
J Natl Cancer Inst; 2013 Dec; 105(23):1814-20. PubMed ID: 24231453
[TBL] [Abstract][Full Text] [Related]
36. Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States.
Tavakkoli A; Singal AG; Waljee AK; Elmunzer BJ; Pruitt SL; McKey T; Rubenstein JH; Scheiman JM; Murphy CC
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):171-178.e10. PubMed ID: 31202981
[TBL] [Abstract][Full Text] [Related]
37. More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancer.
Barrington DA; Sinnott JA; Nixon D; Padamsee TJ; Cohn DE; Doll KM; Donneyong MM; Felix AS
Am J Obstet Gynecol; 2022 Aug; 227(2):244.e1-244.e17. PubMed ID: 35283091
[TBL] [Abstract][Full Text] [Related]
38. Analyzing the Impact of Compliance with National Guidelines for Pancreatic Cancer Care Using the National Cancer Database.
Jaap K; Fluck M; Hunsinger M; Wild J; Arora T; Shabahang M; Blansfield J
J Gastrointest Surg; 2018 Aug; 22(8):1358-1364. PubMed ID: 29594911
[TBL] [Abstract][Full Text] [Related]
39. Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer.
Macedo FI; Ryon E; Maithel SK; Lee RM; Kooby DA; Fields RC; Hawkins WG; Williams G; Maduekwe U; Kim HJ; Ahmad SA; Patel SH; Abbott DE; Schwartz P; Weber SM; Scoggins CR; Martin RCG; Dudeja V; Franceschi D; Livingstone AS; Merchant NB
Ann Surg; 2019 Sep; 270(3):400-413. PubMed ID: 31283563
[TBL] [Abstract][Full Text] [Related]
40. Racial disparities in the treatment of advanced epithelial ovarian cancer.
Howell EA; Egorova N; Hayes MP; Wisnivesky J; Franco R; Bickell N
Obstet Gynecol; 2013 Nov; 122(5):1025-1032. PubMed ID: 24104782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]